Clopidogrel
- Product NDC
- 63629-4728
- 11-digit product format
- 636294728
- Labeler code
- 63629
- Product ID
- 63629-4728_4a22874a-ae21-4da8-b1c5-6732e9b00825
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clopidogrel
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA076999
- Marketing category
- ANDA
- Marketing start
- 2012-05-17
- Marketing end
- 0000-00-00
- Substance
- CLOPIDOGREL BISULFATE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 63629-4728-1 | 2024-01-30 | C162847 | 48780-1 | 9855e2a2-4c29-60a7-e053-dbdaa90a05bd | These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 |
| 63629-4728-2 | 2024-01-30 | C162847 | 48780-1 | 9855e2a2-4c29-60a7-e053-dbdaa90a05bd | These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 |
| 63629-4728-3 | 2024-01-30 | C162847 | 48780-1 | 9855e2a2-4c29-60a7-e053-dbdaa90a05bd | These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 |
| 63629-4728-4 | 2024-01-30 | C162847 | 48780-1 | 9855e2a2-4c29-60a7-e053-dbdaa90a05bd | These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 |
| 63629-4728-5 | 2024-01-30 | C162847 | 48780-1 | 9855e2a2-4c29-60a7-e053-dbdaa90a05bd | These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 |
| 63629-4728-1 | 2022-02-16 | C162847 | 48780-1 | 9855e2a2-4c29-60a7-e053-dbdaa90a05bd | These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 |
| 63629-4728-2 | 2022-02-16 | C162847 | 48780-1 | 9855e2a2-4c29-60a7-e053-dbdaa90a05bd | These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 |
| 63629-4728-3 | 2022-02-16 | C162847 | 48780-1 | 9855e2a2-4c29-60a7-e053-dbdaa90a05bd | These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 |
| 63629-4728-4 | 2022-02-16 | C162847 | 48780-1 | 9855e2a2-4c29-60a7-e053-dbdaa90a05bd | These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 |
| 63629-4728-1 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-4c29-60a7-e053-dbdaa90a05bd | These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 |
| 63629-4728-2 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-4c29-60a7-e053-dbdaa90a05bd | These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 |
| 63629-4728-3 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-4c29-60a7-e053-dbdaa90a05bd | These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 |
| 63629-4728-4 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-4c29-60a7-e053-dbdaa90a05bd | These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63629-4728-1 | Clopidogrel | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | | 1002 |
| 63629-4728-2 | Clopidogrel | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 1002 |
| 63629-4728-3 | Clopidogrel | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | | 1002 |
| 63629-4728-4 | Clopidogrel | 20 in 1 BOTTLE | TABLET, FILM COATED | 20 | | 1002 |
| 63629-4728-5 | Clopidogrel | 10 in 1 BOTTLE | TABLET, FILM COATED | 10 | | 1002 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CLOPIDOGREL BISULFATE | ACTIVE INGREDIENT | 08I79HTP27 | CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| CLOPIDOGREL | ACTIVE MOIETY | A74586SNO7 | CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| COCHINEAL | INACTIVE INGREDIENT | TZ8Z31B35M | CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| HYDROGENATED COTTONSEED OIL | INACTIVE INGREDIENT | Z82Y2C65EA | CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| HYDROXYPROPYL CELLULOSE | INACTIVE INGREDIENT | RFW2ET671P | CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| HYPROMELLOSE 2910 (15 MPA.S) | INACTIVE INGREDIENT | 36SFW2JZ0W | CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63629-4728 | CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1002 | Legacy NDC, 5 package rows | 20220217_4a22874a-ae21-4da8-b1c5-6732e9b00825.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63629-4728-1 | 63629472801 | 90 TABLET, FILM COATED in 1 BOTTLE (63629-4728-1) | 2012-05-29 | 0000-00-00 | No | No | Current |
| 63629-4728-2 | 63629472802 | 30 TABLET, FILM COATED in 1 BOTTLE (63629-4728-2) | 2012-08-21 | 0000-00-00 | No | No | Current |
| 63629-4728-3 | 63629472803 | 60 TABLET, FILM COATED in 1 BOTTLE (63629-4728-3) | 2014-07-31 | 0000-00-00 | No | No | Current |
| 63629-4728-4 | 63629472804 | 20 TABLET, FILM COATED in 1 BOTTLE (63629-4728-4) | 2022-02-08 | 0000-00-00 | No | No | Current |
| 63629-4728-5 | 63629472805 | 10 TABLET, FILM COATED in 1 BOTTLE (63629-4728-5) | 2022-02-08 | 0000-00-00 | No | No | Current |